Shreyas Kulkarni

Shreyas Kulkarni

Auto-generated profile, based on publicly available information

Shreyas Kulkarni

Warren Alpert Medical School of Brown University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013
Verified
Conference Paper
Closed access
SKShreyas Kulkarni
Shreyas Kulkarni
SJSarang Junghare
Sarang Junghare
Autrebot; indoor trash detection and collection system using autonomously directed robotic exploration algorithm is presented. The algorithm has linear time complexity and is developed using two ultrasonic sensors. The key feature of this algorithm is the acquisition of object location based on the sensor output. The two sensor interface is specially implemented for intelligent decision making and proper identification of the object of interest, ignoring stray mobile objects or walls. Pneumatic actuators are used for the pickup and disposal of trash once it has been successfully located. Experiments with the algorithm have been conducted in static as well as dynamic environments and its performance analyzed for multiple scenarios. The algorithm can be thus extended for locating a particular object of interest based on its physical attributes.

22 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
AKAndrew Kalra
Andrew Kalra
PBPreetham Bachina
Preetham Bachina
BSBenjamin L. Shou
Benjamin L. Shou
JHJaeho Hwang
Jaeho Hwang
MBMeylakh Barshay
Meylakh Barshay
Sung-Min ChoSung-Min Cho
Sung-Min Cho
Background: Venovenous extracorporeal membrane oxygenation (VV-ECMO) is associated with acute brain injury (ABI), including central nervous system (CNS) ischemia (defined as ischemic stroke or hypoxic-ischemic brain injury) and intracranial hemorrhage (ICH). There is limited data on prediction models for ABI and neurological outcomes in VV-ECMO. Research Question: Can machine learning (ML) accurately predict ABI and identify modifiable factors of ABI in VV-ECMO? Study Design and Methods: We analyzed adult (≥18 years) VV-ECMO patients in the Extracorporeal Life Support Organization Registry (2009-2021) from 676 centers. ABI was defined as CNS ischemia, ICH, brain death, and seizures. Overall, 65 total variables were extracted including clinical characteristics and pre-ECMO and on-ECMO variables. Random Forest, CatBoost, LightGBM, and XGBoost ML algorithms (10-fold leave-one-out cross-validation) were used to predict ABI. Feature Importance Scores were used to pinpoint variables most important for predicting ABI. Results: Of 37,473 VV-ECMO patients (median age=48.1 years, 63% male), 2,644 (7.1%) experienced ABI: 610 (2%) and 1,591 (4%) experienced CNS ischemia and ICH, respectively. The median ECMO duration was 10 days (interquartile range=5-20 days). The area under the receiver-operating characteristics curves to predict ABI, CNS ischemia, and ICH were 0.67, 0.63, and 0.70, respectively. The accuracy, positive predictive, and negative predictive values for ABI were 79%, 15%, and 95%, respectively. ML identified pre-ECMO cardiac arrest as the most important risk factor for ABI while ECMO duration and bridge to transplantation as an indication for ECMO were associated with lower risk of ABI. Interpretation: This is the first study to use machine learning to predict ABI in a large cohort of VV-ECMO patients. Performance was sub-optimal due to the low reported prevalence of ABI with lack of standardization of neuromonitoring/imaging protocols and data granularity in the ELSO Registry. Standardized neurological monitoring and imaging protocols may improve machine learning performance to predict ABI.

11 January 2024 in Research Square
Verified
Preprint
Open access
PDF file
AKAndrew Kalra
Andrew Kalra
PBPreetham Bachina
Preetham Bachina
BSBenjamin L. Shou
Benjamin L. Shou
JHJaeho Hwang
Jaeho Hwang
MBMeylakh Barshay
Meylakh Barshay
Sung-Min ChoSung-Min Cho
Sung-Min Cho
Objective: To determine if machine learning (ML) can predict acute brain injury (ABI) and identify modifiable risk factors for ABI in venoarterial extracorporeal membrane oxygenation (VA-ECMO) patients. Design: Retrospective cohort study of the Extracorporeal Life Support Organization (ELSO) Registry (2009-2021). Setting: International, multicenter registry study of 676 ECMO centers. Patients: Adults (≥18 years) supported with VA-ECMO or extracorporeal cardiopulmonary resuscitation (ECPR). Interventions: None. Measurements and Main Results: Our primary outcome was ABI: central nervous system (CNS) ischemia, intracranial hemorrhage (ICH), brain death, and seizures. We utilized Random Forest, CatBoost, LightGBM and XGBoost ML algorithms (10-fold leave-one-out cross-validation) to predict and identify features most important for ABI. We extracted 65 total features: demographics, pre-ECMO/on-ECMO laboratory values, and pre-ECMO/on-ECMO settings. Of 35,855 VA-ECMO (non-ECPR) patients (median age=57.8 years, 66% male), 7.7% (n=2,769) experienced ABI. In VA-ECMO (non-ECPR), the area under the receiver-operator characteristics curves (AUC-ROC) to predict ABI, CNS ischemia, and ICH was 0.67, 0.67, and 0.62, respectively. The true positive, true negative, false positive, false negative, positive, and negative predictive values were 33%, 88%, 12%, 67%, 18%, and 94%, respectively for ABI. Longer ECMO duration, higher 24h ECMO pump flow, and higher on-ECMO PaO2 were associated with ABI. Of 10,775 ECPR patients (median age=57.1 years, 68% male), 16.5% (n=1,787) experienced ABI. The AUC-ROC for ABI, CNS ischemia, and ICH was 0.72, 0.73, and 0.69, respectively. The true positive, true negative, false positive, false negative, positive, and negative predictive values were 61%, 70%, 30%, 39%, 29% and 90%, respectively, for ABI. Longer ECMO duration, younger age, and higher 24h ECMO pump flow were associated with ABI. Conclusions: This is the largest study predicting neurological complications on sufficiently powered international ECMO cohorts. Longer ECMO duration and higher 24h pump flow were associated with ABI in both non-ECPR and ECPR VA-ECMO.

3 April 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
ZZZhusi Zhong
Zhusi Zhong
JLJie Li
Jie Li
SKShreyas Kulkarni
Shreyas Kulkarni
HZHelen Zhang Zhang
Helen Zhang Zhang
FFFayez H. Fayad
Fayez H. Fayad
ZJZhicheng Jiao
Zhicheng Jiao
Health disparities among marginalized populations with lower socioeconomic status significantly impact the fairness and effectiveness of healthcare delivery. The increasing integration of artificial intelligence (AI) into healthcare presents an opportunity to address these inequalities, provided that AI models are free from bias. This paper aims to address the bias challenges by population disparities within healthcare systems, existing in the presentation of and development of algorithms, leading to inequitable medical implementation for conditions such as pulmonary embolism (PE) prognosis. In this study, we explore the diversity of biases in healthcare systems, which highlights the need for a holistic framework to reduce bias by complementary aggregation. By leveraging de-biasing deep survival prediction models, we propose a framework that disentangles identifiable information from images, text reports, and clinical variables to mitigate potential biases within multimodal datasets. Our study offers several advantages over traditional clinical-based survival prediction methods, including richer survival-related characteristics and bias-complementary predicted results. By improving the robustness of survival analysis through this framework, we aim to benefit patients, clinicians, and researchers by improving fairness and accuracy in healthcare AI systems. The code is available at https://github.com/zzs95/fairPE-SA.

30 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DBDhaval P. Bhatt
Dhaval P. Bhatt
CMC. Allie Mills
C. Allie Mills
KAKristin A. Anderson
Kristin A. Anderson
BHBárbara J. Henriques
Bárbara J. Henriques
TLTânia G. Lucas
Tânia G. Lucas
MHMatthew D. Hirschey
Matthew D. Hirschey
A wide range of protein acyl modifications has been identified on enzymes across various metabolic processes; however, the impact of these modifications remains poorly understood. Protein glutarylation is a recently identified modification that can be non-enzymatically driven by glutaryl-CoA. In mammalian systems, this unique metabolite is only produced in the lysine and tryptophan oxidative pathways. To better understand the biology of protein glutarylation, we studied the relationship between enzymes within the lysine/tryptophan catabolic pathways, protein glutarylation, and regulation by the deglutarylating enzyme Sirtuin 5 (SIRT5). Here, we identify glutarylation on the lysine oxidation pathway enzyme glutaryl-CoA dehydrogenase (GCDH). We show increased GCDH glutarylation when glutaryl-CoA production is stimulated by lysine catabolism. Our data reveal glutarylation of GCDH impacts its function, ultimately decreasing lysine oxidation. We then demonstrate the ability of SIRT5 to deglutarylate GCDH, restoring its enzymatic activity. Finally, metabolomic and bioinformatic analyses indicate an expanded role for SIRT5 in regulating amino acid metabolism. Together, these data support a model whereby a feedback loop exists within the lysine/tryptophan oxidation pathway, in which glutaryl-CoA is produced, in turn inhibiting GCDH function via glutaryl modification of GCDH lysine residues, and can be relieved by SIRT5 deacylation activity.